Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mengting Gao

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Journal for Immunotherapy of Cancer|February 1, 2024
Prognostic and predictive value of angiogenesis-associated serum proteins for immunotherapy in esophageal cancerMengting Gao, Xueying Wu, Xi Jiao, et al.
JAMA Network Open|March 29, 2022
Characteristics and Prognosis of Acquired Resistance to Immune Checkpoint Inhibitors in Gastrointestinal CancerNa Zhuo, Chang Liu, Qi Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 30, 2026
NIR-II-Trackable LYTACs Phyto-Nanotheranostics for Source-Microenvironment Dual-Track ROS Regulation in Acute Gouty ArthritisJian Zhang, Yingying Wang, Lujie Yu, et al.
Frontiers in Immunology|September 26, 2022
Serological biomarkers predict immune-related adverse events and clinical benefit in patients with advanced gastrointestinal cancersYanni Wang, Jianling Zou, Yun Li, et al.
Signal Transduction and Targeted Therapy|June 27, 2024
Clinical efficacy and identification of factors confer resistance to afatinib (tyrosine kinase inhibitor) in EGFR-overexpressing esophageal squamous cell carcinomaYanni Wang, Chang Liu, Huan Chen, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Journal for Immunotherapy of Cancer|February 1, 2024
Prognostic and predictive value of angiogenesis-associated serum proteins for immunotherapy in esophageal cancerMengting Gao, Xueying Wu, Xi Jiao, et al.
JAMA Network Open|March 29, 2022
Characteristics and Prognosis of Acquired Resistance to Immune Checkpoint Inhibitors in Gastrointestinal CancerNa Zhuo, Chang Liu, Qi Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 30, 2026
NIR-II-Trackable LYTACs Phyto-Nanotheranostics for Source-Microenvironment Dual-Track ROS Regulation in Acute Gouty ArthritisJian Zhang, Yingying Wang, Lujie Yu, et al.
Frontiers in Immunology|September 26, 2022
Serological biomarkers predict immune-related adverse events and clinical benefit in patients with advanced gastrointestinal cancersYanni Wang, Jianling Zou, Yun Li, et al.
Signal Transduction and Targeted Therapy|June 27, 2024
Clinical efficacy and identification of factors confer resistance to afatinib (tyrosine kinase inhibitor) in EGFR-overexpressing esophageal squamous cell carcinomaYanni Wang, Chang Liu, Huan Chen, et al.
Pageof 4